Top Markets
#1 Islamic Coin Islamic Coin +151.47%
#2 DOVU DOVU +49.90%
#3 Black Phoenix Black Phoenix +34.71%
#4 Velvet Velvet +26.93%
#5 DoubleZero DoubleZero +13.36%
#6 Akedo Akedo +13.09%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.82%
#8 HOME HOME +11.04%
#9 Cross Cross +10.90%
#10 Fake World Assets Fake World Assets +9.79%
Coin of the day
Islamic Coin Islamic Coin
設定
言語
日本
通貨
USD
テーマ
MabCure Inc. MabCure Inc.

MabCure Inc.

MBCI
株式のランク #41404
MabCure Inc., a development stage company, engages in developing and... MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
株価
$0.0003
最終同期: 2026-08-12
時価総額
$21.97K
変化（1日）
0.00%
変化（1年）
200.00%
国
US
取引 MabCure Inc. (MBCI)

カテゴリー

Healthcare
MabCure Inc.（MBCI）の利益
2026 時点の利益 TTM: 0
MabCure Inc. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
MabCure Inc. の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US